These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 6761145

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up.
    Winkel LP, Van den Hout JM, Kamphoven JH, Disseldorp JA, Remmerswaal M, Arts WF, Loonen MC, Vulto AG, Van Doorn PA, De Jong G, Hop W, Smit GP, Shapira SK, Boer MA, van Diggelen OP, Reuser AJ, Van der Ploeg AT.
    Ann Neurol; 2004 Apr; 55(4):495-502. PubMed ID: 15048888
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. First trimester diagnosis of Pompe's disease (glycogenosis type II) with normal outcome: assay of acid alpha-glucosidase in chorionic villous biopsy using antibodies.
    Grubisic A, Shin YS, Meyer W, Endres W, Becker U, Wischerath H.
    Clin Genet; 1986 Oct; 30(4):298-301. PubMed ID: 3098466
    [Abstract] [Full Text] [Related]

  • 48. A severe form of non-classic Pompe's disease with normal creatinine kinase level.
    Demirkol D, Caliskan M, Gökcay G, Yanni D, Citak A, Oflazer PS, Karaböcüoğlu M.
    Neuropediatrics; 2010 Aug; 41(4):193-5. PubMed ID: 21086226
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Severe course of glycogen storage disease type II (Pompe's disease) without development of cardiomegalia.
    Ullrich K, Gröbe H, Korinthenberg R, von Bassewitz DB.
    Pathol Res Pract; 1986 Oct; 181(5):627-32. PubMed ID: 2947052
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. A family with different clinical forms of acid maltase deficiency (glycogenosis type II): biochemical and genetic studies.
    Loonen MC, Busch HF, Koster JF, Martin JJ, Niermeijer MF, Schram AW, Brouwer-Kelder B, Mekes W, Slee RG, Tager JM.
    Neurology; 1981 Oct; 31(10):1209-16. PubMed ID: 6810200
    [Abstract] [Full Text] [Related]

  • 54. Enzyme inhibitory assay using monoclonal antibody against acid alpha-D-glucosidase in prenatal diagnosis to identify homozygotes of Pompe's disease.
    Wei CY, Yeh GP, Chen HF, Wang LY, Lin CY.
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992 Oct; 33(2):104-11. PubMed ID: 1514400
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Biosynthesis of lysosomal enzymes in fibroblasts. Phosphorylation of mannose residues.
    Hasilik A, Neufeld EF.
    J Biol Chem; 1980 May 25; 255(10):4946-50. PubMed ID: 6989822
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Enzyme replacement therapy in Pompe's disease].
    Merk T, Wibmer T, Schumann C, Krüger S.
    Med Klin (Munich); 2007 Jul 15; 102(7):570-3. PubMed ID: 17634875
    [Abstract] [Full Text] [Related]

  • 60. Immunocytochemical analysis of normal and acid maltase-deficient muscle cultures.
    Miranda AF, Shanske S, Hays AP, DiMauro S.
    Arch Neurol; 1985 Apr 15; 42(4):371-3. PubMed ID: 3921010
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.